SEC SCHEDULE 13G

Company

Karyopharm Therapeutics Inc.

Filed

October 11, 2016

Accession Number

0000902219-16-001225

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →